title: [Drug therapies following heart failure and myocardial infarction(discussion)].
authors.forename: Takeshi
authors.initials: T
authors.lastname: Shimizu
authors.forename: Issei
authors.initials: I
authors.lastname: Komuro
authors.forename: Haruo
authors.initials: H
authors.lastname: Hirayama
authors.forename: Shinya
authors.initials: S
authors.lastname: Hiramitsu
authors.forename: Kiyokazu
authors.initials: K
authors.lastname: Shimizu
authors.forename: Osamu
authors.initials: O
authors.lastname: Yoshida
mesh_terms: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use; D001713:Biphenyl Compounds; D006332:Cardiomegaly / Q000188:drug therapy / Q000209:etiology; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000209:etiology; D011945:Receptors, Angiotensin; D012084:Renin-Angiotensin System / Q000502:physiology; D013314:Stress, Mechanical; D013777:Tetrazoles / Q000494:pharmacology / Q000627:therapeutic use; D020257:Ventricular Remodeling
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D011945:Receptors, Angiotensin; D013777:Tetrazoles; C081643:candesartan